US-based molecular diagnostics company Co-Diagnostics has announced that its partner, Clinical Reference Laboratory (CRL), has secured FDA Emergency Use Authorization for CRL Rapid Response. The saliva-based Covid-19 test can be self-administered at home, or any other setting, and then tested using Co-Diagnostics’ CoPrimer technology.
South Korea-based biotech firm Macrogen has secured the CE marking for In-Vitro Diagnostic (CE-IVD) devices for its Covid-19 test kit, Axen COVID-19 RT. The CE-IVD is an important certification in Europe for the distribution of in-vitro diagnostic reagents. The test kit uses RT-PCR, and can confirm whether the person is infected with Covid-19 in just two hours, allowing large numbers of tests to be conducted quickly and efficiently. Given that the kit identifies ORF1ab and E genes, the two genes related to Covid-19, it is claimed to have a high level of accuracy and target detection.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Decision Diagnostics, through its subsidiary Pharma Tech Solutions, has announced its support for the FDA Covid-19 At-Home Use Template recently issued. The firm stated that it “contains much of what was in our May 1st At-Home Application to the FDA.” The firm added that is now preparing to amend its first EUA submission PEUA200947 for its GenViro! Blood Swift Kit for at-home use. Soon after that, the company expects to file a separate EUA application with the FDA for its GenViro! Saliva Swift Kit for home use.
